Hostname: page-component-594f858ff7-pr6g6 Total loading time: 0 Render date: 2023-06-06T17:18:20.446Z Has data issue: false Feature Flags: { "corePageComponentGetUserInfoFromSharedSession": false, "coreDisableEcommerce": false, "corePageComponentUseShareaholicInsteadOfAddThis": true, "coreDisableSocialShare": false, "useRatesEcommerce": true } hasContentIssue false

The impact of fruit flavonoids on memory and cognition

Published online by Cambridge University Press:  19 October 2010

Jeremy P. E. Spencer*
Molecular Nutrition Group, School of Chemistry, Food and Pharmacy, University of Reading, ReadingRG2 6AP, UK Centre for Integrative Neuroscience and Neurodynamics, University of Reading, ReadingRG2 6AP, UK
*Corresponding author: J. P. E. Spencer, email
Rights & Permissions[Opens in a new window]


There is intense interest in the studies related to the potential of phytochemical-rich foods to prevent age-related neurodegeneration and cognitive decline. Recent evidence has indicated that a group of plant-derived compounds known as flavonoids may exert particularly powerful actions on mammalian cognition and may reverse age-related declines in memory and learning. In particular, evidence suggests that foods rich in three specific flavonoid sub-groups, the flavanols, anthocyanins and/or flavanones, possess the greatest potential to act on the cognitive processes. This review will highlight the evidence for the actions of such flavonoids, found most commonly in fruits, such as apples, berries and citrus, on cognitive behaviour and the underlying cellular architecture. Although the precise mechanisms by which these flavonoids act within the brain remain unresolved, the present review focuses on their ability to protect vulnerable neurons and enhance the function of existing neuronal structures, two processes known to be influenced by flavonoids and also known to underpin neuro-cognitive function. Most notably, we discuss their selective interactions with protein kinase and lipid kinase signalling cascades (i.e. phosphoinositide-3 kinase/Akt and mitogen-activated protein kinase pathways), which regulate transcription factors and gene expression involved in both synaptic plasticity and cerebrovascular blood flow. Overall, the review attempts to provide an initial insight into the potential impact of regular flavonoid-rich fruit consumption on normal or abnormal deteriorations in cognitive performance.

Full Papers
Copyright © The Author 2010

Ageing is associated with many common chronic neurodegenerative diseases and the precise cause of the neuronal degeneration underlying these disease and, indeed, normal brain ageing remains unclear. It is thought that several cellular and molecular events are involved, including increases in oxidative stress, impaired mitochondria function, activation of neuronal apoptosis, the deposition of aggregated proteins and excitotoxicity. Thus far, the majority of existing drug treatments for the treatment of neurodegenerative disorders are unable to prevent the underlying degeneration of neurons and consequently there is a desire to develop alternative therapies capable of preventing the progressive loss of specific neuronal populations. Since the neuropathology of many neurodegenerative diseases has been linked to increases in brain oxidative stress, historically, strong efforts have been directed at exploring the antioxidant strategies to combat neuronal damage. Indeed, there has been intense interest in the neuroprotective effects of a group of plant secondary metabolites known as polyphenols, which are powerful antioxidants in vitro. A large number of dietary intervention studies in human subjects(Reference Macready, Kennedy and Ellia1) and animals(Reference Rendeiro, Spencer and Vauzour2), in particular those using foods and beverages derived from Vitis vinifera (grape), Camellia sinensis (tea), Theobroma cacao (cocoa) and Vaccinium spp. (blueberry), have demonstrated beneficial effects on human vascular function and on improving memory and learning(Reference Rendeiro, Spencer and Vauzour2Reference Joseph, Cole and Head13). While such foods and beverages differ greatly in chemical composition, macronutrient and micronutrient content and energy load/serving, they have in common that they are among the major dietary sources of a group of phytochemicals called flavonoids (for review on source, structure and bioavailability, refer to Spencer et al. and Rice-Evans et al. (Reference Spencer, Abd El Mohsen and Minihane14, Reference Rice-Evans, Miller and Paganga15)).

Evidence has begun to emerge that these low molecular weight, non-nutrient components may be responsible for the beneficial effects of flavonoid-rich foods in vivo, through their ability to directly or indirectly interact with the brain's innate architecture for memory(Reference Williams, El Mohsen and Vauzour16, Reference Spencer17). Historically, the biological actions of flavonoids on the brain were attributed to their ability to exert antioxidant actions(Reference Rice-Evans, Miller and Paganga15), through their ability to scavenge reactive species or through their possible influences on intracellular redox status(Reference Pollard, Kuhnle and Vauzour18). However, it is now clear that this classical hydrogen-donating antioxidant activity cannot account for the bioactivity of flavonoids in vivo, particularly in the brain, where they are found at only very low concentrations(Reference Spencer19). Instead, it has been postulated that their effects in the brain are mediated by an ability to protect vulnerable neurons, enhance existing neuronal function, stimulate brain blood flow and induce neurogenesis(Reference Spencer6). In vitro work has indicated that flavonoids and their physiological metabolites are capable of inducing neuronal and glial signalling pathways crucial in inducing synaptic plasticity(Reference Williams, Spencer and Rice-Evans20Reference Vauzour, VafeiAdou and Rodriguez-Mateos22), but only at low nanomolar concentrations(Reference Vauzour, VafeiAdou and Rice-Evans23) similar to that reported in the brain(Reference Williams, El Mohsen and Vauzour16). However, their interaction with these pathways has wider relevance, as these signalling pathways are also responsible for determining the fate of neurons following exposure to neurotoxins(Reference Weinreb, Amit and Mandel24) and inflammatory mediators(Reference Spencer17) and in controlling cerebrovascular blood flow. The present review examines the potential for flavonoids and flavonoid-rich fruits to influence brain function and the mechanisms that might be responsible for such actions in the brain.

Modulation of memory and cognition by flavonoid-rich fruits

A recent prospective study has provided strong evidence that dietary flavonoid intake is associated with better cognitive evolution, i.e. the preservation of cognitive performance with ageing(Reference Letenneur, Proust-Lima and Le25). Furthermore, there is much evidence to suggest that flavonoids found in fruits and fruit juices (most notably flavanols, flavanones and anthocyanins) have the capacity to improve memory(Reference Spencer6, Reference Spencer19, Reference Shukitt-Hale, Lau and Joseph26Reference Shukitt-Hale, Lau and Joseph28). A number of animal intervention studies, using diets containing between 1 and 2 % (w/w) freeze-dried fruit/fruit juice, have indicated that grape, pomegranate, strawberry and blueberry, as well as pure flavonoids (epicatechin and quercetin), are capable of affecting several aspects of memory and learning, notably rapid(Reference Wang, Wang and Wu11) and slow(Reference Joseph, Shukitt-Hale and Denisova29Reference Winter32) memory acquisition, short-term working memory(Reference Williams, El Mohsen and Vauzour16, Reference Hoffman, Donato and Robbins33Reference Pu, Mishima and Irie36), long-term reference memory(Reference Haque, Hashimoto and Katakura9, Reference Casadesus, Shukitt-Hale and Stellwagen37), reversal learning(Reference Wang, Wang and Wu11, Reference Hoffman, Donato and Robbins33) and memory retention/retrieval(Reference van Praag, Lucero and Yeo38). For example, fruits such as strawberry, blueberry and blackberry (all rich in anthocyanins and flavanols) have been shown to be beneficial in retarding functional, age-related CNS and cognitive behavioural deficits(Reference Joseph, Shukitt-Hale and Denisova29, Reference Joseph, Shukitt-Hale and Denisova39, Reference Shukitt-Hale, Cheng and Joseph40). There is also extensive evidence that berries, most notably blueberries, which are equally rich in both anthocyanin and flavanols, are effective at reversing age-related deficits in spatial working memory(Reference Williams, El Mohsen and Vauzour16, Reference Ramirez, Izquierdo and do Carmo Bassols35, Reference Casadesus, Shukitt-Hale and Stellwagen37, Reference Shukitt-Hale, Cheng and Joseph40Reference Barros, Amaral and Izquierdo46). Furthermore, the effects of blueberry and blackberry appear to be most pronounced in terms of short-term memory, suggesting that these improvements are, in part, dependent on CA3–CA3 excitatory connections in the hippocampus(Reference Shukitt-Hale, Cheng and Joseph40, Reference Rolls and Kesner47). Although it is presently uncertain as to whether it is the flavonoids within these fruits which are causal agents in inducing the behavioural effects, evidence is beginning to emerge that suggests they are able to induce both behavioural and related cellular changes. For example, the flavanol ( − )-epicatechin (500 μg/g), which is found in a variety of fruits (apple, pear, grape and all berries), has been shown to enhance the retention of rat spatial memory in water maze tasks, especially when combined with exercise(Reference van Praag, Lucero and Yeo38). This improvement was associated with increased angiogenesis and neuronal spine density in the dentate gyrus (DG) of the hippocampus and with the up-regulation of genes associated with learning in the hippocampus.

Alternatively, the blueberry-derived flavonoids may act to enhance the efficiency of spatial memory indirectly by acting on the DG, the hippocampal sub-region most sensitive to the effects of ageing(Reference Burke and Barnes48). DG granule cells are particularly vulnerable to the ageing process(Reference Small, Tsai and DeLaPaz49, Reference Small, Chawla and Buonocore50), with age-dependent degeneration resulting in an impairment of information transfer between DG and CA3, thus resulting in an inability of CA3 networks to build new spatial representations(Reference Burke and Barnes48). This is supported by observations that DG lesioned animals exhibit marked difficulties in acquiring spatial representations(Reference Xavier, Oliveira-Filho and Santos51). Blueberry supplementation has been shown to significantly increase the proliferation of precursor cells in the DG of aged rats(Reference Casadesus, Shukitt-Hale and Stellwagen37). This link between DG neurogenesis, cognitive performance and ageing is well documented(Reference Kuhn, Dickinson-Anson and Gage52Reference Stangl and Thuret56) and may represent another mechanism by which fruits rich in flavonoids may improve memory by acting on the hippocampus. Again, it is unclear at present whether flavonoids themselves are wholly responsible for the effects of flavonoid-rich fruits in vivo and also whether they induce global changes in hippocampal (and other brain region) morphology/function or are they capable of more specific changes in hippocampal sub-regions. In the next section, we examine the known interactions of flavonoids with the cellular structures and processes involved in normal brain function in an attempt to better understand how these actions might underpin the wide range of beneficial actions of flavonoid-rich fruits on mammalian cognitive processing.

Mechanisms of action

There is now much evidence to suggest that fruit-derived phytochemicals, in particular flavonoids, are capable of promoting beneficial effects on memory and learning(Reference Williams, El Mohsen and Vauzour16, Reference Shukitt-Hale, Lau and Joseph26, Reference Joseph, Shukitt-Hale and Denisova29, Reference Joseph, Shukitt-Hale and Denisova39, Reference Joseph, Denisova and Arendash43, Reference Joseph, Shukitt-Hale and Casadesus57Reference Shukitt-Hale, Carey and Simon59). It appears that they are able to impact upon memory through their ability to exert effects directly on the brain's innate architecture for memory(Reference Spencer6). This cellular architecture is well known to deteriorate with ageing with neuronal populations or synaptic connections lost over time, leaving the system less efficient in the processing and storage of sensory information. The next three sections describe how specific flavonoids or flavonoid-rich fruits impact upon this innate cellular architecture and thereby influence cognitive processing and ultimately behavioural outcomes such as memory.

Interaction with neuronal signalling and synaptic function

The ability of flavonoids to impact upon memory appears to be, in part, underpinned by their ability to interact with the molecular and physiological apparatus used in normal memory processing(Reference Spencer21, Reference Joseph, Shukitt-Hale and Lau60). The concentrations of flavonoids and their metabolites that reach the brain following dietary supplementation are believed to be in the region of 10–300 nm. Such concentrations are sufficiently high to exert pharmacological activity at receptors, kinases and transcription factors(Reference Williams, Spencer and Rice-Evans20). Although the precise site of their interaction with signalling pathways remains unresolved, evidence indicates that they are capable of acting in a number of ways: (1) by binding to ATP sites on enzymes and receptors; (2) by modulating the activity of kinases directly, i.e. MAPKKK, MAPKK or MAPK; (3) by affecting the function of important phosphatases, which act in opposition to kinases; (4) by modulating transcription factor activation and binding to promoter sequences, i.e. cyclicAMP-response element-binding protein (reviewed in Spencer(Reference Spencer21, Reference Spencer61)) (Fig. 1).

Fig. 1 Flavonoid-induced activation and inhibition of neuronal and glial signalling and functional implications. Activation of extracellular receptor kinase (ERK), Akt and cyclicAMP-response element-binding protein (CREB) by flavonoids may promote changes in synaptic plasticity and neurogenesis, which ultimately influence memory, learning and cognition. Activation of these pathways may also lead to the inhibition of pro-apoptotic signalling in neurons (bad and caspases). Flavonoid-induced inhibition of the c-jun N-terminal kinases (JNK), apoptosis signal-regulating kinase-1 and p38 pathways leads to an inhibition of both the apoptosis in neurons and a reduction of neuroinflammatory reactions in microglia (reduction in inductible nitric oxide synthase (iNOS) expression and NO∙ release). PKB, protein kinase B; mTOR, mammalian target of rapamycin; STAT-1, signal transducers and activators of transcription family-1; c-jun, c-jun N-terminal kinases; NO, nitric oxide; BDNF, brain-derived neurotrophic factor; VEGF, vascular endothelial growth factor; TGF, tumour growth factor.

Flavonoids and flavonoid-rich fruits are well reported to modulate neuronal signalling pathways crucial in inducing synaptic plasticity(Reference Spencer21), in particular with the extracellular receptor kinase and protein kinase B/Akt pathways(Reference Spencer61Reference Schroeter, Bahia and Spencer63). The activation of these pathways has been observed in vivo following dietary intervention with blueberry (2 % (w/w) freeze-dried blueberry), along with the activation of the transcription factor cyclicAMP-response element-binding protein and production of neurotrophins such as brain-derived neurotrophic factor, which are known to be required during memory acquisition and consolidation. Agents, both dietary and otherwise, capable of inducing pathways leading to cyclicAMP-response element-binding protein activation are believed to have the potential to enhance both short-term and long-term memories(Reference Williams, El Mohsen and Vauzour16), through the initiation of processes leading to the generation of a more efficient structure for interpreting afferent nerve or sensory information. One mechanism by which this may come about is through flavonoid-induced increases in neuronal spine density and morphology, two factors considered vital for learning and memory(Reference Harris and Kater64).

Changes in spine density, morphology and motility have been shown to occur with paradigms that induce synaptic, as well as altered sensory experience, and lead to alterations in synaptic connectivity and strength between neuronal partners, which ultimately affects the efficacy of synaptic communication (Fig. 1). In support of this, dietary supplementation with blueberries rich in both high flavanol and anthocyanin has been shown to cause activation of mammalian target of rapamycin and an increased expression of hippocampal Arc/Arg3·1(Reference Williams, El Mohsen and Vauzour16), events which are likely to facilitate changes in synaptic strength through the stimulation of the growth of small dendritic spines into large mushroom-shaped spines. The ability of flavonoids to induce such morphological changes through interactions with neuronal signalling is supported by studies which have shown that specific flavanols are capable of inducing neuronal dendrite outgrowth(Reference Reznichenko, Amit and Youdim65). Furthermore, nobiletin, a poly-methoxylated flavone found in citrus peel, also induces neurite outgrowth(Reference Nagase, Yamakuni and Matsuzaki66) and synaptic transmission(Reference Matsuzaki, Miyazaki and Sakai67) via its ability to interact directly with mitogen-activated protein kinase and PKA signalling pathways, while its metabolite, 4′-demethylnobiletin, exerts similar effects via the same pathways(Reference Al, Nakajima and Saigusa68). While these effects are interesting, and in agreement with previous observations with flavonoids, it should be noted that they were observed at concentrations ranging from 10 to 100 μM, which are unlikely to be achieved in the brain.

Influence on blood flow and neurogenesis

There is also evidence to suggest that flavonoid-rich foods may be capable of preventing many forms of cerebrovascular disease including those associated with stroke and dementia(Reference Commenges, Scotet and Renaud69, Reference Dai, Borenstein and Wu70). It is thought that flavonoids meditate these effects in vivo through their potential to affect endothelial function and peripheral blood flow(Reference Schroeter, Heiss and Balzer71). Such vascular effects are potentially significant as increased cerebrovascular function is known to facilitate adult neurogenesis in the hippocampus(Reference Gage72) (Fig. 1). Indeed, new hippocampal cells are clustered near blood vessels, which proliferate in response to vascular growth factors and may influence memory(Reference Palmer, Willhoite and Gage73). Efficient cerebral blood flow (CBF) is vital for optimal brain function, with several studies indicating that there is a decrease in CBF in patients with dementia(Reference Nagahama, Nabatame and Okina74, Reference Ruitenberg, den Heijer and Bakker75). Brain imaging techniques, such as ‘functional MRI’ and ‘trans-cranial Doppler ultrasound’, have shown that there is a correlation between CBF and cognitive function in human subjects(Reference Ruitenberg, den Heijer and Bakker75). For example, CBF velocity is significantly lower in patients with Alzheimer disease and low CBF is also associated with incipient markers of dementia. In contrast, non-demented subjects with higher CBF were less likely to develop dementia.

In this context, flavanol-rich foods have been shown to cause significantly increased CBF in human subjects, 1–2 h postintervention(Reference Francis, Head and Morris76, Reference Fisher, Sorond and Hollenberg77). Although requiring further investigation, intervention with a flavanol-rich drink derived from cocoa (400–900 mg flavanols) resulted in an acute (2 h postintervention) increase in blood flow (blood oxygen level-dependent functionalMRI) in certain regions of the brain, along with a modification of the blood oxygen level-dependent response in individuals completing a ‘task switching’ test. Furthermore, ‘arterial spin-labelling sequence MRI’(Reference Wang, Fernandez-Seara and Alsop78) also indicated that cocoa flavanols increase CBF up to a maximum of 2 h after ingestion of the flavanol-rich drink. In support of these findings, an increase in CBF through the middle cerebral artery has been reported after the consumption of flavanol-rich cocoa using trans-cranial Doppler ultrasound(Reference Fisher, Sorond and Hollenberg77). Clearly, further investigation is required before one can be certain of the full impact of flavonoids-rich foods on brain blood flow. At present, there is very little information regarding the ability of other flavonoid-rich foods, including effect of fruits on cerebrovascular blood flow. However, if such responses are ultimately dependent on the actions of flavanols on the vascular system, as has been suggested(Reference Schroeter, Heiss and Balzer71), then there is good reason to hypothesise that other flavanol-rich foods, such as apple, grape, blackcurrant and pear, may also possess similar activity.

Inhibition of neurodegeneration and neuroinflammation

The underlying neurodegeneration observed in Parkinson's, Alzheimer's and other neurodegenerative diseases is believed to be triggered by multi-factorial processes, including neuroinflammation(Reference Hirsch, Hunot and Hartmann79, Reference McGeer and McGeer80), glutamatergic excitotoxicity and increases in Fe and/or depletion of endogenous antioxidants(Reference Barzilai and Melamed81Reference Spires and Hannan83). There is a growing body of evidence to suggest that flavonoids and flavonoid-rich foods may be capable of counteracting such neuronal injury, thereby delaying the progression of disease pathologies(Reference Spencer19, Reference Vauzour, VafeiAdou and Rodriguez-Mateos22, Reference Spencer61, Reference Mandel and Youdim84). The death of nigral neurons in Parkinson's disease is thought to involve the formation of the endogenous neurotoxin, 5-S-cysteinyl-dopamine and its oxidation product, dihydrobenzothiazine-1(Reference Vauzour, Ravaioli and VafeiAdou5, Reference Spencer, Whiteman and Jenner85Reference Spencer, Jenner and Daniel87). However, the generation of 5-S-cysteinyl-dopamine(Reference Vauzour, Vafeiadou and Spencer88) and resulting neuronal injury induced by it are effectively counteracted by a range of flavonoids and other polyphenols found commonly in a range of fruits such as orange, berries, apple and grape(Reference Vauzour, Ravaioli and VafeiAdou5). There is also evidence that flavanols and their metabolites are effective in blocking oxidant-induced neuronal injury(Reference Spencer, Schroeter and Kuhnle89, Reference Spencer, Schroeter and Crossthwaithe90) at concentrations relevant to those observed in vivo and in the brain (typically 10–300 nm), through their ability to modulate PI3 kinase (PI3K)/Akt and mitogen-activated protein kinase signalling(Reference Williams, Spencer and Rice-Evans20, Reference Spencer61). For example, the flavanols epicatechin and 3′-O-methyl-epicatechin (100 and 300 nm) protect neurons against oxidative damage via a mechanism involving the suppression of c-jun N-terminal kinases, and downstream partners, c-jun and pro-caspase-3(Reference Schroeter, Spencer and Rice-Evans91) (Fig. 1). Similarly, the citrus flavanones, hesperetin and its metabolite, 5-nitro-hesperetin (10–300 nm), inhibit oxidant-induced neuronal apoptosis via a mechanism involving the activation/phosphorylation of signalling proteins important in the pro-survival pathways(Reference Vauzour, VafeiAdou and Rice-Evans92).

Recent evidence suggests that non-steroidal, anti-inflammatory drugs are effective in delaying the onset of neurodegenerative disorders, particularly Parkinson's disease(Reference Casper, Yaparpalvi and Rempel93). As such, there has been an interest in the development of new compounds with an ability to counteract neuroinflammatory injury to the brain. The citrus flavanone naringenin (300 nm) has recently been found to be highly effective in reducing lipopolysaccharide/interferon-γ-induced glial-cell activation and resulting neuronal injury, via inhibition of p38 and signal transducers and activators of transcription family-1, and a reduction in inductible nitric oxide synthase expression and other flavonoids has been shown to partially alleviate neuroinflammation through the inhibition of TNF-α production(Reference VafeiAdou, Vauzour and Lee94) (Fig. 1). Flavonoids present in blueberry have also been shown to inhibit NO∙, IL-1β and TNF-α production in activated microglia cells(Reference Lau, Bielinski and Joseph95), while the flavonol quercetin (1–30 μm) (96) and the flavanols catechin and epigallocatechin gallate (1–50 μm)(Reference Li, Huang and Fang97) have all been shown to attenuate microglia- and/or astrocyte-mediated neuroinflammation. As with their activity against oxidative stress, their ability to exert such actions appears to rely on their ability to directly modulate kinase signalling pathways, pro-inflammatory transcription factors and the downstream regulation of inductible nitric oxide synthase and cyclooxygenase-2 expression, NO∙ production, cytokine release and NADPH oxidase activation(Reference Williams, Spencer and Rice-Evans20, Reference Spencer21, Reference Spencer61, Reference Bhat, Zhang and Lee98). For example, flavonol fisetin (1 μm), which is found in strawberry and other fruits, has been shown to inhibit p38 mitogen-activated protein kinase phosphorylation in LPS-stimulated BV-2 microglial cells(Reference Zheng, Ock and Kwon99) and the flavone luteolin (5–50 μm) inhibits IL-6 production in activated microglia via inhibition of the c-jun N-terminal kinases signalling pathway(Reference Jang, Kelley and Johnson100).

Summary and future horizons

The actions of flavonoid-rich fruits and the specific flavonoids that they contain on brain function appear to express significant similarity. This suggests that the ability of many fruits to exert effects on cognition appears to be underpinned by their flavonoid content and involves a number of effects, including a potential to protect neurons against injury induced by neurotoxins and neuroinflammation, a potential to activate synaptic signalling and an ability to improve cerebrovascular blood flow. These effects appear to be mediated by the interaction of flavonoids and their physiological metabolites with cellular signalling cascades in the brain and the periphery, leading to an inhibition of apoptosis triggered by neurotoxic species, the promotion of neuronal survival and differentiation and an enhancement of peripheral and cerebral blood perfusion. Such effects induce beneficial changes in the cellular architecture required for cognition and consequently provide the brain with a more efficient structure for interpreting afferent nerve or sensory information and for the storage, processing and retrieval of memory. Furthermore, such interactions also protect the brain against neuronal losses associated with ageing, something which is particularly relevant as this innate brain structure is known to deteriorate with ageing, with neuronal populations or synaptic connections lost over time, leaving the system less efficient in its ability to process sensory information.

The consumption of flavonoid-rich fruits, such as berries, apple and citrus, throughout life may have the potential to limit or even reverse age-dependent deteriorations in memory and cognition. However, there are a number of questions still to be resolved. Most notably, at present, there is no data in support of a causal relationship between the consumption of flavonoids and behavioural outcomes in human subjects. In order to make such relationships, future intervention studies will be required to utilise better-characterised intervention materials, more appropriate controls and more rigorous clinical outcomes. While cognitive behavioural testing in human subjects and animals provides an appropriate way of assessing function, in vivo structural and dynamic quantitative assessments will ultimately be required to provide hard evidence of effects in the brain. For example, it would be highly advantageous to directly link behavioural responses to changes in hippocampal volume and density, changes in neural stem cell and progenitor cells and alterations in brain blood flow using MRI and functional MRI techniques. Functional MRI measures may be used to assess changes in blood flow that underlie improved cognitive functioning as a result of flavonoid-rich fruit supplementation. In addition, such haemodynamic changes may be further compared with changes in grey matter density and with biomarkers of neural stem and progenitor cells, using proton NMR spectroscopy. Such an approach will be essential to provide links between flavonoid intake and brain function in a mechanistic, dynamic and quantitative way. Taking such an approach, one may also be able to assess other factors relating to intake such as the timeframe required to gain maximum beneficial effects, the flavonoids most effective in inducing these changes and the doses at which these become effective?

Furthermore, it appears that the precise mechanism by which flavonoids act on cognitive performance appears to be dependent on the period of flavonoid exposure. At present, improvements in cognition resulting from acute dietary flavonoid-rich fruit interventions are thought to be dependent on increased cerebrovascular blood flow. However, in vitro studies using physiological doses of flavonoids have shown that they are able to rapidly stimulate neuronal signalling pathways involved in cognitive processing and thus even acute changes in cognition may be partly mediated by their direct actions on neurons. In order to resolve this issue, further studies are necessary to clearly resolve the issue of whether flavonoids are able to localise in the brain following the consumption of flavonoid-rich fruits. In human subjects, this can only be resolved by the use of brain imaging technologies allied to intervention studies utilising 13C-labelled flavonoids (either pure 13C-labelled flavonoids or with fruits harvested from plants grown in a 13CO2 environment). Cognitive changes associated with long-term intake of fruit flavonoids are more likely to involve morphological changes triggered by the direct actions of flavonoids on neuronal signalling. However, the extent to which daily acute changes in brain blood flow impact upon such changes are presently unknown. Thus, future studies are necessary and should be designed to resolve the precise temporal nature of their effects on memory as well as other issues, such as when one needs to start consuming flavonoids to gain the maximum beneficial effects?

Finally, the potential impact of diet on health care costs should not be ignored. Dementia costs to the UK alone have been estimated to be £17 billion/annum. If scientists could develop a treatment that would reduce severe cognitive impairment in older people by just 1 % per year, this would cancel out all estimated increases in the long-term care costs due to our ageing population (Alzheimer's Research Trust). Beyond this, there is also intense interest in the development of drugs capable of enhancing memory and learning, both in adults and in children, and there is a strong possibility that in the future, specific nutrients, in particular fruit-derived flavonoids, might act as precursors for the development of a new generation of memory-enhancing drugs. As such, the present series of reviews in this issue are extremely timely one and highlight the present thinking in the field and outline the future directions for research in the area.


J. P. E. S. is funded by the Biotechnology and Biological Sciences Research Council (BB/F008953/1; BB/E023185/1; BB/G005702/1), the FSA (FLAVURS) and the European Union (FP7 FLAVIOLA). There is no conflict of interest that I should disclose, having read the Journals guidelines. J. P. E. S. is the sole author of the manuscript.


1 Macready, AL, Kennedy, OB, Ellia, JA, et al. (2009) Flavonoids and cognitive function: a review of human randomized controlled trial studies and recommendations for future studies. Genes Nutr 4, 227242.CrossRefGoogle ScholarPubMed
2 Rendeiro, C, Spencer, JPE, Vauzour, D, et al. (2009) The impact of flavonoids on spatial memory in rodents: from behaviour to underlying hippocampal mechanisms. Genes Nutr 4, 251270.CrossRefGoogle ScholarPubMed
3 Spencer, JPE, Vauzour, D & Rendeiro, C (2009) Flavonoids and cognition: the molecular mechanisms underlying their behavioural effects. Arch Biochem Biophys 492, 19.CrossRefGoogle ScholarPubMed
4 Checkoway, H, Powers, K, Smith-Weller, T, et al. (2002) Parkinson's disease risks associated with cigarette smoking, alcohol consumption, and caffeine intake. Am J Epidemiol 155, 732738.CrossRefGoogle ScholarPubMed
5 Vauzour, D, Ravaioli, G, VafeiAdou, K, et al. (2008) Peroxynitrite induced formation of the neurotoxins 5-S-cysteinyl-dopamine and DHBT-1: implications for Parkinson's disease and protection by polyphenols. Arch Biochem Biophys 476, 145151.CrossRefGoogle ScholarPubMed
6 Spencer, JPE (2008) Food for thought: the role of dietary flavonoids in enhancing human memory, learning and neuro-cognitive performance. Proc Nutr Soc 67, 238252.CrossRefGoogle ScholarPubMed
7 Galli, RL, Shukitt-Hale, B, Youdim, KA, et al. (2002) Fruit polyphenolics and brain aging: nutritional interventions targeting age-related neuronal and behavioral deficits. Ann N Y Acad Sci 959, 128132.CrossRefGoogle ScholarPubMed
8 Unno, K, Takabayashi, F, Kishido, T, et al. (2004) Suppressive effect of green tea catechins on morphologic and functional regression of the brain in aged mice with accelerated senescence (SAMP10). Exp Gerontol 39, 10271034.CrossRefGoogle Scholar
9 Haque, AM, Hashimoto, M, Katakura, M, et al. (2006) Long-term administration of green tea catechins improves spatial cognition learning ability in rats. J Nutr 136, 10431047.Google ScholarPubMed
10 Kuriyama, S, Hozawa, A, Ohmori, K, et al. (2006) Green tea consumption and cognitive function: a cross-sectional study from the Tsurugaya Project 1. Am J Clin Nutr 83, 355361.Google ScholarPubMed
11 Wang, Y, Wang, L, Wu, J, et al. (2006) The in vivo synaptic plasticity mechanism of EGb 761-induced enhancement of spatial learning and memory in aged rats. Br J Pharmacol 148, 147153.CrossRefGoogle ScholarPubMed
12 Youdim, KA, Shukitt-Hale, B & Joseph, JA (2004) Flavonoids and the brain: interactions at the blood–brain barrier and their physiological effects on the central nervous system. Free Radic Biol Med 37, 16831693.CrossRefGoogle ScholarPubMed
13 Joseph, J, Cole, G, Head, E, et al. (2009) Nutrition, brain aging, and neurodegeneration. J Neurosci 29, 1279512801.CrossRefGoogle ScholarPubMed
14 Spencer, JPE, Abd El Mohsen, MM, Minihane, AM, et al. (2007) Biomarkers of the intake of dietary polyphenols: strengths, limitations and application in nutrition research. Br J Nutr 99, 1222.Google ScholarPubMed
15 Rice-Evans, CA, Miller, NJ & Paganga, G (1996) Structure-antioxidant activity relationships of flavonoids and phenolic acids. Free Radic Biol Med 20, 933956.CrossRefGoogle ScholarPubMed
16 Williams, CM, El Mohsen, MA, Vauzour, D, et al. (2008) Blueberry-induced changes in spatial working memory correlate with changes in hippocampal CREB phosphorylation and brain-derived neurotrophic factor (BDNF) levels. Free Radic Biol Med 45, 295305.CrossRefGoogle ScholarPubMed
17 Spencer, JPE (2009) Flavonoids and brain health: multiple effects underpinned by common mechanisms. Genes Nutr 4, 243250.CrossRefGoogle Scholar
18 Pollard, SE, Kuhnle, GG, Vauzour, D, et al. (2006) The reaction of flavonoid metabolites with peroxynitrite. Biochem Biophys Res Commun 350, 960968.CrossRefGoogle ScholarPubMed
19 Spencer, JPE (2008) Flavonoids: modulators of brain function? Br J Nutr 99E, Suppl. 1, ES60ES77.Google Scholar
20 Williams, RJ, Spencer, JPE & Rice-Evans, C (2004) Flavonoids: antioxidants or signalling molecules? Free Radic Biol Med 36, 838849.CrossRefGoogle ScholarPubMed
21 Spencer, JPE (2009) The impact of flavonoids on memory: physiological and molecular considerations. Chem Soc Rev 38, 11521161.CrossRefGoogle ScholarPubMed
22 Vauzour, D, VafeiAdou, K, Rodriguez-Mateos, A, et al. (2008) The neuroprotective potential of flavonoids: a multiplicity of effects. Genes Nutr 3, 115126.CrossRefGoogle Scholar
23 Vauzour, D, VafeiAdou, K, Rice-Evans, C, et al. (2007) Activation of pro-survival Akt and ERK1/2 signalling pathways underlie the anti-apoptotic effects of flavanones in cortical neurons. J Neurochem 103, 13551367.CrossRefGoogle ScholarPubMed
24 Weinreb, O, Amit, T, Mandel, S, et al. (2009) Neuroprotective molecular mechanisms of ( − )-epigallocatechin-3-gallate: a reflective outcome of its antioxidant, iron chelating and neuritogenic properties. Genes Nutr 4, 283296.CrossRefGoogle ScholarPubMed
25 Letenneur, L, Proust-Lima, C, Le, GA, et al. (2007) Flavonoid intake and cognitive decline over a 10-year period. Am J Epidemiol 165, 13641371.CrossRefGoogle Scholar
26 Shukitt-Hale, B, Lau, FC & Joseph, JA (2008) Berry fruit supplementation and the aging brain. J Agric Food Chem 56, 636641.CrossRefGoogle ScholarPubMed
27 Shukitt-Hale, B, Carey, AN, Jenkins, D, et al. (2007) Beneficial effects of fruit extracts on neuronal function and behavior in a rodent model of accelerated aging. Neurobiol Aging 28, 11871194.CrossRefGoogle Scholar
28 Shukitt-Hale, B, Lau, FC & Joseph, JA (2008) Berry fruit supplementation and the aging brain. J Agric Food Chem 56, 636641.CrossRefGoogle ScholarPubMed
29 Joseph, JA, Shukitt-Hale, B, Denisova, NA, et al. (1999) Reversals of age-related declines in neuronal signal transduction, cognitive, and motor behavioral deficits with blueberry, spinach, or strawberry dietary supplementation. J Neurosci 19, 81148121.Google ScholarPubMed
30 Shif, O, Gillette, K, Damkaoutis, CM, et al. (2006) Effects of Ginkgo biloba administered after spatial learning on water maze and radial arm maze performance in young adult rats. Pharmacol Biochem Behav 84, 1725.CrossRefGoogle ScholarPubMed
31 Hartman, RE, Shah, A, Fagan, AM, et al. (2006) Pomegranate juice decreases amyloid load and improves behavior in a mouse model of Alzheimer's disease. Neurobiol Dis 24, 506515.CrossRefGoogle Scholar
32 Winter, JC (1998) The effects of an extract of Ginkgo biloba, EGb 761, on cognitive behavior and longevity in the rat. Physiol Behav 63, 425433.CrossRefGoogle ScholarPubMed
33 Hoffman, JR, Donato, A & Robbins, SJ (2004) Ginkgo biloba promotes short-term retention of spatial memory in rats. Pharmacol Biochem Behav 77, 533539.CrossRefGoogle ScholarPubMed
34 Walesiuk, A, Trofimiuk, E & Braszko, JJ (2006) Ginkgo biloba normalizes stress- and corticosterone-induced impairment of recall in rats. Pharmacol Res 53, 123128.CrossRefGoogle ScholarPubMed
35 Ramirez, MR, Izquierdo, I, do Carmo Bassols, RM, et al. (2005) Effect of lyophilised Vaccinium berries on memory, anxiety and locomotion in adult rats. Pharmacol Res 52, 457462.CrossRefGoogle ScholarPubMed
36 Pu, F, Mishima, K, Irie, K, et al. (2007) Neuroprotective effects of quercetin and rutin on spatial memory impairment in an 8-arm radial maze task and neuronal death induced by repeated cerebral ischemia in rats. J Pharmacol Sci 104, 329334.CrossRefGoogle Scholar
37 Casadesus, G, Shukitt-Hale, B, Stellwagen, HM, et al. (2004) Modulation of hippocampal plasticity and cognitive behavior by short-term blueberry supplementation in aged rats. Nutr Neurosci 7, 309316.CrossRefGoogle ScholarPubMed
38 van Praag, H, Lucero, MJ, Yeo, GW, et al. (2007) Plant-derived flavanol ( − )-epicatechin enhances angiogenesis and retention of spatial memory in mice. J Neurosci 27, 58695878.CrossRefGoogle ScholarPubMed
39 Joseph, JA, Shukitt-Hale, B, Denisova, NA, et al. (1998) Long-term dietary strawberry, spinach, or vitamin E supplementation retards the onset of age-related neuronal signal-transduction and cognitive behavioral deficits. J Neurosci 18, 80478055.Google ScholarPubMed
40 Shukitt-Hale, B, Cheng, V & Joseph, JA (2009) Effects of blackberries on motor and cognitive function in aged rats. Nutr Neurosci 12, 135140.CrossRefGoogle ScholarPubMed
41 Andres-Lacueva, C, Shukitt-Hale, B, Galli, RL, et al. (2005) Anthocyanins in aged blueberry-fed rats are found centrally and may enhance memory. Nutr Neurosci 8, 111120.CrossRefGoogle ScholarPubMed
42 Goyarzu, P, Malin, DH, Lau, FC, et al. (2004) Blueberry supplemented diet: effects on object recognition memory and nuclear factor-kappa B levels in aged rats. Nutr Neurosci 7, 7583.CrossRefGoogle ScholarPubMed
43 Joseph, JA, Denisova, NA, Arendash, G, et al. (2003) Blueberry supplementation enhances signaling and prevents behavioral deficits in an Alzheimer disease model. Nutr Neurosci 6, 153162.CrossRefGoogle Scholar
44 Barros, D, Amaral, OB, Izquierdo, I, et al. (2006) Behavioral and genoprotective effects of Vaccinium berries intake in mice. Pharmacol Biochem Behav 84, 229234.CrossRefGoogle ScholarPubMed
45 Willis, LM, Shukitt-Hale, B & Joseph, JA (2009) Recent advances in berry supplementation and age-related cognitive decline. Curr Opin Clin Nutr Metab Care 12, 9194.CrossRefGoogle ScholarPubMed
46 Barros, D, Amaral, OB, Izquierdo, I, et al. (2006) Behavioral and genoprotective effects of Vaccinium berries intake in mice. Pharmacol Biochem Behav 84, 229234.CrossRefGoogle ScholarPubMed
47 Rolls, ET & Kesner, RP (2006) A computational theory of hippocampal function, and empirical tests of the theory. Prog Neurobiol 79, 148.CrossRefGoogle Scholar
48 Burke, SN & Barnes, CA (2006) Neural plasticity in the ageing brain. Nat Rev Neurosci 7, 3040.CrossRefGoogle ScholarPubMed
49 Small, SA, Tsai, WY, DeLaPaz, R, et al. (2002) Imaging hippocampal function across the human life span: is memory decline normal or not? Ann Neurol 51, 290295.CrossRefGoogle ScholarPubMed
50 Small, SA, Chawla, MK, Buonocore, M, et al. (2004) Imaging correlates of brain function in monkeys and rats isolates a hippocampal subregion differentially vulnerable to aging. Proc Natl Acad Sci U S A 101, 71817186.CrossRefGoogle ScholarPubMed
51 Xavier, GF, Oliveira-Filho, FJ & Santos, AM (1999) Dentate gyrus-selective colchicine lesion and disruption of performance in spatial tasks: difficulties in ‘place strategy’ because of a lack of flexibility in the use of environmental cues? Hippocampus 9, 668681.3.0.CO;2-9>CrossRefGoogle Scholar
52 Kuhn, HG, Dickinson-Anson, H & Gage, FH (1996) Neurogenesis in the dentate gyrus of the adult rat: age-related decrease of neuronal progenitor proliferation. J Neurosci 16, 20272033.Google ScholarPubMed
53 Kempermann, G, Kuhn, HG & Gage, FH (1998) Experience-induced neurogenesis in the senescent dentate gyrus. J Neurosci 18, 32063212.Google ScholarPubMed
54 Drapeau, E, Mayo, W, Aurousseau, C, et al. (2003) Spatial memory performances of aged rats in the water maze predict levels of hippocampal neurogenesis. Proc Natl Acad Sci U S A 100, 1438514390.CrossRefGoogle ScholarPubMed
55 Shors, TJ, Townsend, DA, Zhao, M, et al. (2002) Neurogenesis may relate to some but not all types of hippocampal-dependent learning. Hippocampus 12, 578584.CrossRefGoogle Scholar
56 Stangl, D & Thuret, S (2009) Impact of diet on adult hippocampal neurogenesis. Genes Nutr 4, 271282.CrossRefGoogle ScholarPubMed
57 Joseph, JA, Shukitt-Hale, B & Casadesus, G (2005) Reversing the deleterious effects of aging on neuronal communication and behavior: beneficial properties of fruit polyphenolic compounds. Am J Clin Nutr 81, 313S316S.Google ScholarPubMed
58 Joseph, JA, Shukitt-Hale, B & Lau, FC (2007) Fruit polyphenols and their effects on neuronal signaling and behavior in senescence. Ann N Y Acad Sci 1100, 470485.CrossRefGoogle ScholarPubMed
59 Shukitt-Hale, B, Carey, A, Simon, L, et al. (2006) Effects of Concord grape juice on cognitive and motor deficits in aging. Nutrition 22, 295302.CrossRefGoogle Scholar
60 Joseph, JA, Shukitt-Hale, B & Lau, FC (2007) Fruit polyphenols and their effects on neuronal signaling and behavior in senescence. Ann N Y Acad Sci 1100, 470485.CrossRefGoogle ScholarPubMed
61 Spencer, JPE (2007) The interactions of flavonoids within neuronal signalling pathways. Genes Nutr 2, 257273.CrossRefGoogle ScholarPubMed
62 Spencer, JPE, Rice-Evans, C & Williams, RJ (2003) Modulation of pro-survival Akt/protein kinase B and ERK1/2 signaling cascades by quercetin and its in vivo metabolites underlie their action on neuronal viability. J Biol Chem 278, 3478334793.CrossRefGoogle ScholarPubMed
63 Schroeter, H, Bahia, P, Spencer, JPE, et al. (2007) ( − )-Epicatechin stimulates ERK-dependent cyclic AMP response element activity and upregulates GLUR2 in cortical neurons. J Neurochem 101, 15961606.CrossRefGoogle Scholar
64 Harris, KM & Kater, SB (1994) Dendritic spines: cellular specializations imparting both stability and flexibility to synaptic function. Annu Rev Neurosci 17, 341371.CrossRefGoogle ScholarPubMed
65 Reznichenko, L, Amit, T, Youdim, MB, et al. (2005) Green tea polyphenol ( − )-epigallocatechin-3-gallate induces neurorescue of long-term serum-deprived PC12 cells and promotes neurite outgrowth. J Neurochem 93, 11571167.CrossRefGoogle ScholarPubMed
66 Nagase, H, Yamakuni, T, Matsuzaki, K, et al. (2005) Mechanism of neurotrophic action of nobiletin in PC12D cells. Biochemistry 44, 1368313691.CrossRefGoogle ScholarPubMed
67 Matsuzaki, K, Miyazaki, K, Sakai, S, et al. (2008) Nobiletin, a citrus flavonoid with neurotrophic action, augments protein kinase A-mediated phosphorylation of the AMPA receptor subunit, GluR1, and the postsynaptic receptor response to glutamate in murine hippocampus. Eur J Pharmacol 578, 194200.CrossRefGoogle ScholarPubMed
68 Al, RM, Nakajima, A, Saigusa, D, et al. (2009) 4′-Demethylnobiletin, a bioactive metabolite of nobiletin enhancing PKA/ERK/CREB signaling, rescues learning impairment associated with NMDA receptor antagonism via stimulation of the ERK cascade. Biochemistry 48, 77137721.Google Scholar
69 Commenges, D, Scotet, V, Renaud, S, et al. (2000) Intake of flavonoids and risk of dementia. Eur J Epidemiol 16, 357363.CrossRefGoogle Scholar
70 Dai, Q, Borenstein, AR, Wu, Y, et al. (2006) Fruit and vegetable juices and Alzheimer's disease: the Kame Project. Am J Med 119, 751759.CrossRefGoogle ScholarPubMed
71 Schroeter, H, Heiss, C, Balzer, J, et al. (2006) ( − )-Epicatechin mediates beneficial effects of flavanol-rich cocoa on vascular function in humans. Proc Natl Acad Sci U S A 103, 10241029.CrossRefGoogle ScholarPubMed
72 Gage, FH (2000) Mammalian neural stem cells. Science 287, 14331438.CrossRefGoogle ScholarPubMed
73 Palmer, TD, Willhoite, AR & Gage, FH (2000) Vascular niche for adult hippocampal neurogenesis. J Comp Neurol 425, 479494.3.0.CO;2-3>CrossRefGoogle ScholarPubMed
74 Nagahama, Y, Nabatame, H, Okina, T, et al. (2003) Cerebral correlates of the progression rate of the cognitive decline in probable Alzheimer's disease. Eur Neurol 50, 19.CrossRefGoogle ScholarPubMed
75 Ruitenberg, A, den Heijer, T, Bakker, SL, et al. (2005) Cerebral hypoperfusion and clinical onset of dementia: the Rotterdam Study. Ann Neurol 57, 789794.CrossRefGoogle ScholarPubMed
76 Francis, ST, Head, K, Morris, PG, et al. (2006) The effect of flavanol-rich cocoa on the fMRI response to a cognitive task in healthy young people. J Cardiovasc Pharmacol 47, Suppl. 2, S215S220.CrossRefGoogle ScholarPubMed
77 Fisher, ND, Sorond, FA & Hollenberg, NK (2006) Cocoa flavanols and brain perfusion. J Cardiovasc Pharmacol 47, Suppl. 2, S210S214.CrossRefGoogle ScholarPubMed
78 Wang, Z, Fernandez-Seara, M, Alsop, DC, et al. (2008) Assessment of functional development in normal infant brain using arterial spin labeled perfusion MRI. Neuroimage 39, 973978.CrossRefGoogle ScholarPubMed
79 Hirsch, EC, Hunot, S & Hartmann, A (2005) Neuroinflammatory processes in Parkinson's disease. Parkinsonism Relat Disord 11, Suppl.1, S9S15.CrossRefGoogle ScholarPubMed
80 McGeer, EG & McGeer, PL (2003) Inflammatory processes in Alzheimer's disease. Prog Neuropsychopharmacol Biol Psychiatry 27, 741749.CrossRefGoogle ScholarPubMed
81 Barzilai, A & Melamed, E (2003) Molecular mechanisms of selective dopaminergic neuronal death in Parkinson's disease. Trends Mol Med 9, 126132.CrossRefGoogle ScholarPubMed
82 Jellinger, KA (2001) Cell death mechanisms in neurodegeneration. J Cell Mol Med 5, 117.CrossRefGoogle ScholarPubMed
83 Spires, TL & Hannan, AJ (2005) Nature, nurture and neurology: gene–environment interactions in neurodegenerative disease. FEBS Anniversary Prize Lecture delivered on 27 June 2004 at the 29th FEBS Congress in Warsaw. FEBS J 272, 23472361.CrossRefGoogle Scholar
84 Mandel, S & Youdim, MB (2004) Catechin polyphenols: neurodegeneration and neuroprotection in neurodegenerative diseases. Free Radic Biol Med 37, 304317.CrossRefGoogle ScholarPubMed
85 Spencer, JPE, Whiteman, M, Jenner, P, et al. (2002) 5-S-Cysteinyl-conjugates of catecholamines induce cell damage, extensive DNA base modification and increases in caspase-3 activity in neurons. J Neurochem 81, 122129.CrossRefGoogle ScholarPubMed
86 Hastings, TG (1995) Enzymatic oxidation of dopamine: the role of prostaglandin H synthase. J Neurochem 64, 919924.CrossRefGoogle ScholarPubMed
87 Spencer, JPE, Jenner, P, Daniel, SE, et al. (1998) Conjugates of catecholamines with cysteine and GSH in Parkinson's disease: possible mechanisms of formation involving reactive oxygen species. J Neurochem 71, 21122122.CrossRefGoogle ScholarPubMed
88 Vauzour, D, Vafeiadou, K & Spencer, JP (2007) Inhibition of the formation of the neurotoxin 5-S-cysteinyl-dopamine by polyphenols. Biochem Biophys Res Commun 362, 340346.CrossRefGoogle ScholarPubMed
89 Spencer, JPE, Schroeter, H, Kuhnle, G, et al. (2001) Epicatechin and its in vivo metabolite, 3′-O-methyl epicatechin, protect human fibroblasts from oxidative-stress-induced cell death involving caspase-3 activation. Biochem J 354, 493500.CrossRefGoogle ScholarPubMed
90 Spencer, JPE, Schroeter, H, Crossthwaithe, AJ, et al. (2001) Contrasting influences of glucuronidation and O-methylation of epicatechin on hydrogen peroxide-induced cell death in neurons and fibroblasts. Free Radic Biol Med 31, 11391146.CrossRefGoogle ScholarPubMed
91 Schroeter, H, Spencer, JPE, Rice-Evans, C, et al. (2001) Flavonoids protect neurons from oxidized low-density-lipoprotein-induced apoptosis involving c-Jun N-terminal kinase (JNK), c-Jun and caspase-3. Biochem J 358, 547557.CrossRefGoogle Scholar
92 Vauzour, D, VafeiAdou, K, Rice-Evans, C, et al. (2007) Activation of pro-survival Akt and ERK1/2 signaling pathways underlie the anti-apoptotic effects of flavanones in cortical neurons. J Neurochem 103, 13551367.CrossRefGoogle ScholarPubMed
93 Casper, D, Yaparpalvi, U, Rempel, N, et al. (2000) Ibuprofen protects dopaminergic neurons against glutamate toxicity in vitro. Neurosci Lett 289, 201204.CrossRefGoogle ScholarPubMed
94 VafeiAdou, K, Vauzour, D, Lee, HY, et al. (2009) The citrus flavanone naringenin inhibits inflammatory signalling in glial cells and protects against neuroinflammatory injury. Arch Biochem Biophys 484, 100109.CrossRefGoogle ScholarPubMed
95 Lau, FC, Bielinski, DF & Joseph, JA (2007) Inhibitory effects of blueberry extract on the production of inflammatory mediators in lipopolysaccharide-activated BV2 microglia. J Neurosci Res 85, 10101017.CrossRefGoogle ScholarPubMed
96 Chen, JC, Ho, FM, Pei-Dawn, LC, et al. (2005) Inhibition of iNOS gene expression by quercetin is mediated by the inhibition of IkappaB kinase, nuclear factor-kappa B and STAT1, and depends on heme oxygenase-1 induction in mouse BV-2 microglia. Eur J Pharmacol 521, 920.CrossRefGoogle ScholarPubMed
97 Li, R, Huang, YG, Fang, D, et al. (2004) ( − )-Epigallocatechin gallate inhibits lipopolysaccharide-induced microglial activation and protects against inflammation-mediated dopaminergic neuronal injury. J Neurosci Res 78, 723731.CrossRefGoogle ScholarPubMed
98 Bhat, NR, Zhang, P, Lee, JC, et al. (1998) Extracellular signal-regulated kinase and p38 subgroups of mitogen-activated protein kinases regulate inducible nitric oxide synthase and tumor necrosis factor-alpha gene expression in endotoxin-stimulated primary glial cultures. J Neurosci 18, 16331641.Google ScholarPubMed
99 Zheng, LT, Ock, J, Kwon, BM, et al. (2008) Suppressive effects of flavonoid fisetin on lipopolysaccharide-induced microglial activation and neurotoxicity. Int Immunopharmacol 8, 484494.CrossRefGoogle ScholarPubMed
100 Jang, S, Kelley, KW & Johnson, RW (2008) Luteolin reduces IL-6 production in microglia by inhibiting JNK phosphorylation and activation of AP-1. Proc Natl Acad Sci U S A 105, 75347539.CrossRefGoogle ScholarPubMed
Figure 0

Fig. 1 Flavonoid-induced activation and inhibition of neuronal and glial signalling and functional implications. Activation of extracellular receptor kinase (ERK), Akt and cyclicAMP-response element-binding protein (CREB) by flavonoids may promote changes in synaptic plasticity and neurogenesis, which ultimately influence memory, learning and cognition. Activation of these pathways may also lead to the inhibition of pro-apoptotic signalling in neurons (bad and caspases). Flavonoid-induced inhibition of the c-jun N-terminal kinases (JNK), apoptosis signal-regulating kinase-1 and p38 pathways leads to an inhibition of both the apoptosis in neurons and a reduction of neuroinflammatory reactions in microglia (reduction in inductible nitric oxide synthase (iNOS) expression and NO∙ release). PKB, protein kinase B; mTOR, mammalian target of rapamycin; STAT-1, signal transducers and activators of transcription family-1; c-jun, c-jun N-terminal kinases; NO, nitric oxide; BDNF, brain-derived neurotrophic factor; VEGF, vascular endothelial growth factor; TGF, tumour growth factor.